Lori A. Leslie, MD

Director of Indolent Lymphoma and CLL
John Theurer Cancer Center
Hackensack, NJ
On the Speaker’s Bureau of BeiGene, Celgene/ BMS, Epizyme, and Karyopharm; on the Speaker’s Bureau of, has provided consulting to, and has participated in Advisory Boards of AstraZeneca, Janssen, Kite/Gilead, Pharmacyclics, Seattle Genetics, and TG Therapeutics; and has participated in the Advisory Board of and provided consulting to AbbVie, ADC Therapeutics, and Bayer
Last modified: September 27, 2022
Copyright © Engage Healthcare Communications, LLC. All rights reserved.